SOHO Italy 2020

The 2nd Society of Hematological Oncology (SOHO) Italian three-day meeting brings together leading SOHO experts and Italian researchers in acute leukemias, MPNs, and MDS, with the aims of consolidating the Italian Hematology-SOHO partnership.

Highlights from this year’s SOHO Italy Annual Meeting include clinical updates on leukemias, myelodysplastic syndromes, myeloproliferative neoplasms, lymphomas and other related malignancies.

Novel approaches to PV and ET

Novel approaches to PV and ET

Alessandro Lucchesi

Impact of COVID-19 on CLL treatment in Italy

Impact of COVID-19 on CLL treatment in Italy

CLL: state of the art in Italy

CLL: state of the art in Italy

Unmet needs in follicular lymphoma

Unmet needs in follicular lymphoma

Stefano Luminari

Italian perspective: managing lymphoma

Italian perspective: managing lymphoma

Stefano Luminari

New insights in the biology of myeloproliferative neoplasms

New insights in the biology of myeloproliferative neoplasms

Anna Rita Migliaccio

Finding novel targets for myelofibrosis from animal models

Finding novel targets for myelofibrosis from animal models

Anna Rita Migliaccio

Genetic profiling of multiple myeloma in the novel agents era

Genetic profiling of multiple myeloma in the novel agents era

Evolving treatment landscape of DLBCL

Evolving treatment landscape of DLBCL

Gerardo Musuraca

MDS: state of the art in Europe

MDS: state of the art in Europe

Valeria Santini

Optimizing biological agents for ALL

Optimizing biological agents for ALL

Francesco Lanza

Italian perspective: managing DLBCL

Italian perspective: managing DLBCL

Gerardo Musuraca

Phase IV studies: Spanish experience

Phase IV studies: Spanish experience

Adolfo De La Fuente

Balancing efficacy and tolerability in multiple myeloma

Balancing efficacy and tolerability in multiple myeloma

Multiple myeloma: ADCs and BiTEs

Multiple myeloma: ADCs and BiTEs

Changing treatment landscape of AML

Changing treatment landscape of AML

Claudio Cerchione